Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...
At $1.15 a share, the offering is being done on a "best efforts" basis. Subject to usual circumstances, the business ...
Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
Today, the U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...
The FDA is advising users of diabetes devices that rely on smartphones to deliver safety alerts to regularly check their smartphone settings to make sure they're receiving alerts. The agency said it ...
The Food and Drug Administration is warning that critical alerts from diabetes devices may fail to reach users, risking ...
The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical safety alerts.
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...